Epidemiology and Public Health

Rare Diseases & Drug Development

Rare diseases affect small percentage of the population in recent years.  Around 80% of rare diseases are genetic in origin. Cambridge Healthtech Institute’s symposium on #Drug Discovery for Rare Diseases will bring together leading scientists, clinicians, executives and experts who are involved in finding new drug targets and drug modalities for treating rare disorders. This unique one-day event will encourage people from diverse backgrounds to discuss potential opportunities, as well as existing challenges in this field. It’s an opportunity for scientific and technical experts to come together to exchange ideas, experiences and to set up collaborations for rare disease research.